CN112352895A - 一种辅助降血糖的明日叶植物草本固体饮料及制备方法 - Google Patents
一种辅助降血糖的明日叶植物草本固体饮料及制备方法 Download PDFInfo
- Publication number
- CN112352895A CN112352895A CN202011203242.2A CN202011203242A CN112352895A CN 112352895 A CN112352895 A CN 112352895A CN 202011203242 A CN202011203242 A CN 202011203242A CN 112352895 A CN112352895 A CN 112352895A
- Authority
- CN
- China
- Prior art keywords
- parts
- leaf extract
- powder
- angelica keiskei
- assisting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001105098 Angelica keiskei Species 0.000 title claims abstract description 45
- 239000008280 blood Substances 0.000 title claims abstract description 40
- 210000004369 blood Anatomy 0.000 title claims abstract description 40
- 235000013361 beverage Nutrition 0.000 title claims abstract description 32
- 239000007787 solid Substances 0.000 title claims abstract description 32
- 230000001603 reducing effect Effects 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 68
- 239000000843 powder Substances 0.000 claims abstract description 65
- 244000302512 Momordica charantia Species 0.000 claims abstract description 16
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 16
- 241000233779 Cyclocarya paliurus Species 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 14
- 241001365741 Lithocarpus litseifolius Species 0.000 claims abstract description 13
- 229940082477 moringa oleifera leaf extract Drugs 0.000 claims abstract description 13
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 12
- 239000003765 sweetening agent Substances 0.000 claims abstract description 12
- 244000061508 Eriobotrya japonica Species 0.000 claims abstract description 11
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims abstract description 11
- 240000000249 Morus alba Species 0.000 claims abstract description 11
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 11
- 238000011049 filling Methods 0.000 claims abstract description 11
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 10
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 10
- 241000234435 Lilium Species 0.000 claims abstract description 10
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 10
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 10
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 10
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 10
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims abstract description 10
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 10
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 8
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims description 8
- 230000009467 reduction Effects 0.000 claims description 8
- 229920001353 Dextrin Polymers 0.000 claims description 7
- 239000004375 Dextrin Substances 0.000 claims description 7
- 239000003963 antioxidant agent Substances 0.000 claims description 7
- 230000003078 antioxidant effect Effects 0.000 claims description 7
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical group [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 7
- 229960002401 calcium lactate Drugs 0.000 claims description 7
- 239000001527 calcium lactate Substances 0.000 claims description 7
- 235000011086 calcium lactate Nutrition 0.000 claims description 7
- 235000019425 dextrin Nutrition 0.000 claims description 7
- 229930189775 mogroside Natural products 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 235000013355 food flavoring agent Nutrition 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 12
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 239000003472 antidiabetic agent Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 244000179886 Moringa oleifera Species 0.000 description 2
- 235000011347 Moringa oleifera Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 1
- 102000003638 Glucose-6-Phosphatase Human genes 0.000 description 1
- 108010086800 Glucose-6-Phosphatase Proteins 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种辅助降血糖的明日叶植物草本固体饮料及制备方法,涉及固体饮料领域,包括苦瓜粉、青钱柳叶提取物、明日叶提取物、桑叶提取物、枇杷叶提取物、辣木叶提取物、木姜叶柯提取物、薏苡仁粉、百合粉、罗汉果粉、肉桂粉、薄荷粉、甜味剂及填充辅料,本发明提供的辅助降血糖的明日叶植物草本固体饮料,是以多种植物提取物为原料进行优化设计的配方,该配方中的植物活性成分具有协同促进作用,具有显著的辅助降血糖功效,且该固体饮料容易被人体吸收利用,具有很好的亲和性,制备工艺简单,储存运输方式方便其辅助降血糖的作用机理明确,安全性好,无任何副作用。
Description
技术领域
本发明涉及固体饮料领域,尤其涉及一种辅助降血糖的明日叶植物草本固体饮料及制备方法。
背景技术
糖尿病(Diabetes Mellitus,DM)是由遗传因素、免疫功能紊乱、环境因素、精神因素等各种致病因子作用于机体导致胰岛功能减退、胰岛素分泌不足和胰岛素抵抗等而引发的以血糖升高为主要特征的代谢紊乱综合征。近年来发病率处于上升趋势,其危害仅次于肿瘤和心血管疾病,是危害人类健康的第三大疾病。
目前,医学治疗糖尿病作用的降血糖药物种类繁多,2型糖尿病患者主要依靠以口服降糖药和注射胰岛素来维持血糖平衡。传统的降血糖药物如胰岛素、磺脲类、双胍类物质虽能够短时降低血糖,但往往会产生一些副作用,对肝肾的负担大,常引起恶心、呕吐、厌食、食欲减退等不良症状,并且有可能使机体产生依赖性,不宜作为长期预防和治疗之用。
发明内容
本发明所要解决的技术问题是克服现有技术中存在的不足,提供一种辅助降血糖的明日叶植物草本固体饮料及制备方法。
本发明是通过以下技术方案予以实现:一种辅助降血糖的明日叶植物草本固体饮料,包括苦瓜粉、青钱柳叶提取物、明日叶提取物、桑叶提取物、枇杷叶提取物、辣木叶提取物以及木姜叶柯提取物。
根据上述技术方案,优选地,按照重量份数比,包括苦瓜粉20-30份、青钱柳叶提取物10-20份、明日叶提取物3-10份、桑叶提取物5-10份、枇杷叶提取物3-5份、辣木叶提取物1-5份、木姜叶柯提取物1-5份。
根据上述技术方案,优选地,按照重量份数比,还包括薏苡仁粉2-8份、百合粉2-8份、罗汉果粉2-6份、肉桂粉1-2份、薄荷粉0.5-2份、甜味剂0.01-0.1份及填充辅料25-35份。
根据上述技术方案,优选地,按照重量份数比,包括苦瓜粉22.3份、青钱柳叶提取物11.12份、明日叶提取物5.56份、桑叶提取物6.25份、枇杷叶提取物3.45份、辣木叶提取物2份、木姜叶柯提取物2份、薏苡仁粉5份、百合粉5份、罗汉果粉4份、肉桂粉1.6份,薄荷粉1.5份、甜味剂0.05份及填充辅料29.37份。
根据上述技术方案,优选地,甜味剂是罗汉果甜苷。
根据上述技术方案,优选地,填充辅料是抗性糊精。
根据上述技术方案,优选地,还包括抗氧化剂0.01-1.5份,且抗氧化剂为乳酸钙。
一种辅助降血糖的明日叶植物草本固体饮料的制备方法,用于制备辅助降血糖的明日叶植物草本固体饮料,包括以下步骤:
(1)称量,将功效成分、辅料和矫味剂进行精确称量,备用;
(2)混合搅拌,将称量好的功效成分、辅料、甜味剂按照配方进行混合搅拌混合均匀;
(3)灌装、包装入库。
根据上述技术方案,优选地,步骤(2)中采用等量递增方法进行混合搅拌。
本发明的有益效果是:本发明提供的辅助降血糖的明日叶植物草本固体饮料,是以多种植物提取物为原料进行优化设计的配方,该配方中的植物活性成分具有协同促进作用,具有显著的辅助降血糖功效,且该固体饮料容易被人体吸收利用,具有很好的亲和性,制备工艺简单,储存运输方式方便其辅助降血糖的作用机理明确,安全性好,无任何副作用。
具体实施方式
下面将对发明的技术方案进行清楚、完整地描述,显然,所描述的实施例是发明一部分实施例,而不是全部的实施例。基于发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于发明保护的范围。
一种辅助降血糖的明日叶植物草本固体饮料,包括苦瓜粉、青钱柳叶提取物、明日叶提取物、桑叶提取物、枇杷叶提取物、辣木叶提取物以及木姜叶柯提取物。
进一步的,按照重量份数比,包括苦瓜粉20-30份、青钱柳叶提取物10-20份、明日叶提取物3-10份、桑叶提取物5-10份、枇杷叶提取物3-5份、辣木叶提取物1-5份、木姜叶柯提取物1-5份、薏苡仁粉2-8份、百合粉2-8份、罗汉果粉2-6份、肉桂粉1-2份、薄荷粉0.5-2份、甜味剂0.01-0.1份及填充辅料25-35份。
进一步的,甜味剂是罗汉果甜苷。
进一步的,填充辅料是抗性糊精。
进一步的,还包括抗氧化剂0.01-1.5份,且抗氧化剂为乳酸钙。
一种辅助降血糖的明日叶植物草本固体饮料的制备方法,用于制备辅助降血糖的明日叶植物草本固体饮料,包括以下步骤:
(1)称量,将功效成分、辅料和矫味剂进行精确称量,备用;
(2)混合搅拌,将称量好的功效成分、辅料、甜味剂按照配方进行混合搅拌混合均匀;
(3)灌装、包装入库。
根据上述技术方案,优选地,步骤(2)中采用等量递增方法进行混合搅拌,保证功效成分、辅料、矫味剂混合均匀。
实施例1
本实例中,辅助降血糖明日叶植物草本固体饮料,以重量份计包含苦瓜粉22.3份、青钱柳叶提取物11.12份、明日叶提取物5.56份、桑叶提取物6.25份、枇杷叶提取物3.45份、辣木叶提取物2份、木姜叶柯提取物2份、薏苡仁粉5份、百合粉5份、罗汉果粉4份、肉桂粉1.6份,薄荷粉1.5份、罗汉果甜苷0.05份及抗性糊精29.37份。
实施例2
本实例中,辅助降血糖明日叶植物草本固体饮料,以重量份计包含苦瓜粉22.3份、青钱柳叶提取物11.12份、明日叶提取物5.56份、桑叶提取物6.25份、枇杷叶提取物3.45份、辣木叶提取物2份、木姜叶柯提取物2份、薏苡仁粉5份、百合粉5份、罗汉果粉4份、肉桂粉1.6份、薄荷粉1.5份、罗汉果甜苷0.05份、抗性糊精29.37份及乳酸钙0.8份。本实施例与实施例1的区别之处在于乳酸钙的加入,乳酸钙作为抗氧化剂,防止颗粒或粉状食品聚集结块、保持其松散或自由流动。
实施例3
本实例中,辅助降血糖明日叶植物草本固体饮料,以重量份计包含苦瓜粉20份、青钱柳叶提取物10份、明日叶提取物3份、桑叶提取物5份、枇杷叶提取物3份、辣木叶提取物1份、木姜叶柯提取物1份、薏苡仁粉2份、百合粉2份、罗汉果粉2份、肉桂粉1.2份、薄荷粉0.8份、罗汉果甜苷0.01份、抗性糊精28份及乳酸钙1份。
实施例4
本实例中,辅助降血糖明日叶植物草本固体饮料,以重量份计包含苦瓜粉26份、青钱柳叶提取物15份、明日叶提取物8份,桑叶提取物8份、枇杷叶提取物4份、辣木叶提取物3份、木姜叶柯提取物3份、薏苡仁粉7份、百合粉7份、罗汉果粉5份、肉桂粉2份、薄荷粉2份、罗汉果甜苷0.08份、抗性糊精35份及乳酸钙1.2份。
其中苦瓜气味苦、无毒、性寒,入心、肝、脾、肺经具有清暑解渴、降血压、血脂等作用,苦瓜可刺激β细胞分泌胰岛素苦瓜果实和叶子都有促进胰岛细胞分泌胰岛素的作用,影响葡萄糖代谢酶。一方面,苦瓜可抑制葡萄糖-6-磷酸酶和果糖-1,6-二磷酸酶活力,增强己糖激酶活力促进糖原合成等;另一方面通过活化旁路途径的关键酶6-磷酸葡萄糖脱氢酶(G6PDH)而加强葡萄糖的氧化利用;
而青钱柳叶提取物中的主要活性成分为多糖,青钱柳多糖主要通过保护和修复胰岛β细胞、促进病变的胰岛结构功能恢复而发挥调节血糖的作用;
桑叶提取物中含有桑叶黄酮、桑叶多酚、桑叶多糖等多种生理活性物质,用于防治心脑血管病、高脂血症、糖尿病、抗衰老等。其脱氧野尻霉素能竞争性的抑制α-葡萄糖苷酶,具有显著的降血糖作用;
辣木叶是纯天然绿色食品,含有人体所需的全部营养物质,其提取物具有降血糖、降脂、降压、抗肿瘤、抗氧化等功效;
明日叶主要含有黄酮类、香豆素类、萜烯类等活性化学成分,其中明日叶查尔酮可改善胰岛素抗体,从而控制血糖升高。
本发明的有益效果是:本发明提供的辅助降血糖的明日叶植物草本固体饮料,是以多种植物提取物为原料进行优化设计的配方,该配方中的植物活性成分具有协同促进作用,具有显著的辅助降血糖功效,且该固体饮料容易被人体吸收利用,具有很好的亲和性,制备工艺简单,储存运输方式方便其辅助降血糖的作用机理明确,安全性好,无任何副作用。
最后应说明的是:以上各实施例仅用以说明发明的技术方案,而非对其限制;尽管参照前述各实施例对发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离发明各实施例技术方案的范围。
Claims (9)
1.一种辅助降血糖的明日叶植物草本固体饮料,其特征在于,包括苦瓜粉、青钱柳叶提取物、明日叶提取物、桑叶提取物、枇杷叶提取物、辣木叶提取物以及木姜叶柯提取物。
2.根据权利要求1所述的一种辅助降血糖的明日叶植物草本固体饮料,其特征在于,按照重量份数比,包括苦瓜粉20-30份、青钱柳叶提取物10-20份、明日叶提取物3-10份、桑叶提取物5-10份、枇杷叶提取物3-5份、辣木叶提取物1-5份、木姜叶柯提取物1-5份。
3.根据权利要求2所述的一种辅助降血糖的明日叶植物草本固体饮料,其特征在于,按照重量份数比,还包括薏苡仁粉2-8份、百合粉2-8份、罗汉果粉2-6份、肉桂粉1-2份、薄荷粉0.5-2份、甜味剂0.01-0.1份及填充辅料25-35份。
4.根据权利要求3所述的一种辅助降血糖的明日叶植物草本固体饮料,其特征在于,按照重量份数比,包括苦瓜粉22.3份、青钱柳叶提取物11.12份、明日叶提取物5.56份、桑叶提取物6.25份、枇杷叶提取物3.45份、辣木叶提取物2份、木姜叶柯提取物2份、薏苡仁粉5份、百合粉5份、罗汉果粉4份、肉桂粉1.6份,薄荷粉1.5份、甜味剂0.05份及填充辅料29.37份。
5.根据权利要求4所述的一种辅助降血糖的明日叶植物草本固体饮料,其特征在于,所述甜味剂是罗汉果甜苷。
6.根据权利要求5所述的一种辅助降血糖的明日叶植物草本固体饮料,其特征在于,所述填充辅料是抗性糊精。
7.根据权利要求6所述的一种辅助降血糖的明日叶植物草本固体饮料,其特征在于,还包括抗氧化剂0.01-1.5份,且所述抗氧化剂为乳酸钙。
8.一种辅助降血糖的明日叶植物草本固体饮料的制备方法,用于制备权利要求1-7中任意一项所述的辅助降血糖的明日叶植物草本固体饮料,其特征在于,包括以下步骤:
(1)称量,将功效成分、辅料和矫味剂进行精确称量,备用;
(2)混合搅拌,将称量好的功效成分、辅料、甜味剂按照配方进行混合搅拌混合均匀;
(3)灌装、包装入库。
9.根据权利要求8所述的一种辅助降血糖的明日叶植物草本固体饮料的制备方法,其特征在于,步骤(2)中采用等量递增方法进行混合搅拌。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011203242.2A CN112352895A (zh) | 2020-11-02 | 2020-11-02 | 一种辅助降血糖的明日叶植物草本固体饮料及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011203242.2A CN112352895A (zh) | 2020-11-02 | 2020-11-02 | 一种辅助降血糖的明日叶植物草本固体饮料及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112352895A true CN112352895A (zh) | 2021-02-12 |
Family
ID=74512471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011203242.2A Pending CN112352895A (zh) | 2020-11-02 | 2020-11-02 | 一种辅助降血糖的明日叶植物草本固体饮料及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112352895A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003128571A (ja) * | 2001-10-22 | 2003-05-08 | Matsuura Yakugyo Kk | 糖尿病医薬および健康食品 |
CN102727586A (zh) * | 2011-04-02 | 2012-10-17 | 苏州润新生物科技有限公司 | 预防和治疗糖尿病的组合物 |
CN104026192A (zh) * | 2014-06-04 | 2014-09-10 | 上海交通大学 | 薏仁米明日叶营养保健饼干及其制作方法 |
CN106173112A (zh) * | 2016-09-02 | 2016-12-07 | 深圳兴科生物科技有限公司 | 一种清咽润肺茶的配方及其制作方法 |
CN106692297A (zh) * | 2017-02-15 | 2017-05-24 | 云南德彩堂生物医药科技有限公司 | 一种辅助降血糖的组合物及其制备方法和应用 |
CN108324803A (zh) * | 2018-03-23 | 2018-07-27 | 深圳市太空科技南方研究院 | 辅助降血糖的固体饮料及其制备方法 |
CN109497536A (zh) * | 2019-01-18 | 2019-03-22 | 青岛科技大学 | 一种木姜叶柯罗汉果功能性食品及其制备方法 |
-
2020
- 2020-11-02 CN CN202011203242.2A patent/CN112352895A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003128571A (ja) * | 2001-10-22 | 2003-05-08 | Matsuura Yakugyo Kk | 糖尿病医薬および健康食品 |
CN102727586A (zh) * | 2011-04-02 | 2012-10-17 | 苏州润新生物科技有限公司 | 预防和治疗糖尿病的组合物 |
CN104026192A (zh) * | 2014-06-04 | 2014-09-10 | 上海交通大学 | 薏仁米明日叶营养保健饼干及其制作方法 |
CN106173112A (zh) * | 2016-09-02 | 2016-12-07 | 深圳兴科生物科技有限公司 | 一种清咽润肺茶的配方及其制作方法 |
CN106692297A (zh) * | 2017-02-15 | 2017-05-24 | 云南德彩堂生物医药科技有限公司 | 一种辅助降血糖的组合物及其制备方法和应用 |
CN108324803A (zh) * | 2018-03-23 | 2018-07-27 | 深圳市太空科技南方研究院 | 辅助降血糖的固体饮料及其制备方法 |
CN109497536A (zh) * | 2019-01-18 | 2019-03-22 | 青岛科技大学 | 一种木姜叶柯罗汉果功能性食品及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100645385B1 (ko) | 비만 억제용 조성물 | |
CN102511869A (zh) | 红枣生姜浓浆 | |
CN107751993A (zh) | 一种抗疲劳膏滋及其制备方法 | |
KR100815200B1 (ko) | 항비만 효과를 갖는 홍삼 혼합 조성물 | |
CN109694805A (zh) | 一种糖友茗露酒的配方及其制备方法 | |
CN103263054B (zh) | 一种降血压功能性饮品 | |
CN101884408B (zh) | 一种银杏叶浸提液及其制备方法 | |
CN106581115B (zh) | 含芫根和人参的组合物及其应用 | |
KR20150015305A (ko) | 주박 추출물을 유효성분으로 함유하는 비만의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품 | |
KR100601191B1 (ko) | 혈당 강하제 | |
CN112352895A (zh) | 一种辅助降血糖的明日叶植物草本固体饮料及制备方法 | |
CN104997018A (zh) | 一种红豆杉酵素保健品及其制备方法和应用 | |
CN105981853A (zh) | 一种营养功能丰富的温和的暖茶饮料配方 | |
CN104255883A (zh) | 可调血糖和血脂的保健蛋糕及其制作方法 | |
CN107712890A (zh) | 一种宁心安神膏滋及其制备方法 | |
KR102292059B1 (ko) | 인슐리나 및 허니부쉬의 조합추출물을 유효성분으로 포함하는 당뇨 및 당뇨합병증 치료 또는 예방용 조성물 | |
CN102526198A (zh) | 一种以肉桂和铬为添加剂的药品及保健品的制备方法 | |
KR101467407B1 (ko) | 황칠나무 추출물을 유효성분으로 함유하는 혈당조절용 식품 조성물 | |
CN112691150A (zh) | 一种组合物及其制备方法和应用 | |
KR101808808B1 (ko) | 벌나무 및 후박나무 추출물을 함유하는 당뇨병 또는 당뇨합병증 예방 및 치료용 조성물 | |
CN110693029A (zh) | 一种降血糖桑叶苦瓜功能食品 | |
KR20150031373A (ko) | 비타민나무 잎 추출물을 유효성분으로 함유하는 비만 예방 또는 치료용 약학 조성물 및 식품 조성물 | |
KR20100089910A (ko) | 혼합 생약 추출물을 유효성분으로 함유하는 고지혈증 및 당뇨성 고지혈증의 예방 및 치료용 조성물 | |
CN104304379A (zh) | 辅助降血糖的保健保鲜饼干及其制作方法 | |
CN101637214A (zh) | 一种具有防治糖尿病效果的口香糖 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210212 |
|
RJ01 | Rejection of invention patent application after publication |